Balchem Corporation (BCPC)
NASDAQ: BCPC · Real-Time Price · USD
180.81
+3.32 (1.87%)
At close: Feb 13, 2026, 4:00 PM EST
182.90
+2.09 (1.16%)
After-hours: Feb 13, 2026, 5:01 PM EST

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
752.02M723.30M689.60M
United States Revenue Growth
3.97%4.89%1.08%
Foreign Countries Revenue
261.52M230.38M232.84M
Foreign Countries Revenue Growth
13.52%-1.05%-10.49%
Revenue (Total)
1.01B953.68M922.44M
Revenue (Total) Growth
6.28%3.39%-2.11%

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Human Nutrition and Health Revenue
640.62M600.26M550.75M
Human Nutrition and Health Revenue Growth
6.72%8.99%4.48%
Animal Nutrition and Health Revenue
228.01M214.71M238.33M
Animal Nutrition and Health Revenue Growth
6.19%-9.91%-9.14%
Specialty Products Revenue
138.99M132.75M125.97M
Specialty Products Revenue Growth
4.70%5.39%-4.16%
Other and Unallocated Business Segment Revenue
5.93M5.97M7.40M
Other and Unallocated Business Segment Revenue Growth
-0.69%-19.33%-65.58%
Revenue (Total)
1.01B953.68M922.44M
Revenue (Total) Growth
6.28%3.39%-2.11%

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Product Sales Revenue
1.01B951.95M919.95M
Product Sales Revenue Growth
6.28%3.48%-2.05%
Royalty Revenue
1.80M1.74M2.49M
Royalty Revenue Growth
3.34%-30.19%-22.05%
Revenue (Total)
1.01B953.68M922.44M
Revenue (Total) Growth
6.28%3.39%-2.11%

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Human Nutrition and Health Earnings From Operations
150.90M135.96M102.42M
Human Nutrition and Health Earnings From Operations Growth
10.99%32.75%24.71%
Animal Nutrition and Health Earnings From Operations
18.19M14.01M27.58M
Animal Nutrition and Health Earnings From Operations Growth
29.84%-49.18%-23.52%
Specialty Products Earnings From Operations
42.35M39.91M34.58M
Specialty Products Earnings From Operations Growth
6.13%15.40%5.46%
Other and Unallocated Business Segment Earnings From Operations
-6.97M-6.97M-5.38M
Operating Income (Total)
204.48M182.91M159.19M
Operating Income (Total) Growth
11.79%14.90%9.65%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Human Nutrition and Health Backlog
39.96B32.42B
Human Nutrition and Health Backlog Growth
23.26%2.75%
Animal Nutrition and Health Backlog
9.04B7.64B
Animal Nutrition and Health Backlog Growth
18.27%-36.25%
Specialty Products Backlog
1.28B2.68B
Specialty Products Backlog Growth
-52.05%-10.13%
Other Business Segment Backlog
137.00M222.00M
Other Business Segment Backlog Growth
-38.29%-56.38%
Total Backlog
50.42B42.96B
Total Backlog Growth
17.36%-8.64%
Updated Oct 21, 2025. Data Source: Fiscal.ai.